SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Nolen Scott Eric

(Last)

(First)

(Middle)

C/O INTEST CORP

804 EAST GATE DRIVE

(Street)

MT LAUREL

08054

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/09/2022

3. Issuer Name and Ticker or Trading Symbol
INTEST CORP [ INTT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Division Pres-Process Tech

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	14,799.549⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	⁽²⁾	07/30/2029	Common Stock	10,300	$4.53	D
Employee Stock Option (right to buy)	⁽³⁾	04/28/2030	Common Stock	5,140	$3.2	D
Employee Stock Option (right to buy)	⁽⁴⁾	04/27/2031	Common Stock	10,000	$13.13	D

Explanation of Responses:

1. Includes shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. Also consists of (1) 3,400, 1,700 and 3,500 shares granted pursuant to the Issuer's Amended and Restated 2014 Stock Plan (the "Stock Plan") on July 31, 2019, April 29, 2020 and April 28, 2021, respectively, each of which vest 25% annually commencing on the first anniversary of the grant date; and (2) 6,000 shares granted pursuant to the Stock Plan which vest on March 10, 2024 dependent on certain performance criteria. The maximum number of shares that may vest pursuant to the performance criteria is 9,000.

2. Stock option granted on July 31, 2019 pursuant to the Stock Plan and will vest 25% annually commencing on July 31, 2020.

3. Stock option granted on April 29, 2020 pursuant to the Stock Plan and will vest 25% annually commencing on April 29, 2021.

4. Stock option granted on April 28, 2021 pursuant to the Stock Plan and will vest 25% annually commencing on April 28, 2022.

	/s/ Scott Eric Nolen	03/25/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.